Zhi‐Fu Tao
First Affiliated Hospital of Gannan Medical University(CN)
Publications by Year
Research Areas
DNA and Nucleic Acid Chemistry, Cancer therapeutics and mechanisms, Synthesis and Biological Evaluation, Cancer-related Molecular Pathways, DNA Repair Mechanisms
Most-Cited Works
- → lncRNA-MIAT Regulates Microvascular Dysfunction by Functioning as a Competing Endogenous RNA(2015)632 cited
- → Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy(2015)535 cited
- → Discovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity(2014)328 cited
- → Aberrant Expression of Long Noncoding RNAs in Early Diabetic Retinopathy(2014)215 cited
- → Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity(2015)150 cited
- → Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics(2006)129 cited
- → Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor(2020)127 cited
- → Chk1 Inhibitors for Novel Cancer Treatment(2006)92 cited
- → Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors(2007)88 cited
- → Discovery of 3H-Benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM) Kinases(2009)84 cited